Loading...
Verici Dx plc
VRCI.L•LSE
Healthcare
Medical - Diagnostics & Research
£0.55
£0.00(0.00%)
Verici Dx plc (VRCI.L) Financial Performance & Income Statement Overview
Review Verici Dx plc’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
229.62%
↑ 229.62%
Operating Income Growth
31.14%
↑ 31.14%
Net Income Growth
32.75%
↑ 32.75%
Operating Cash Flow Growth
15.92%
↑ 15.92%
Operating Margin
-182.87%
↓ 182.87%
Gross Margin
100.00%
↑ 100.00%
Net Profit Margin
-175.92%
↓ 175.92%
ROE
-133.15%
↓ 133.15%
ROIC
-111.95%
↓ 111.95%
Verici Dx plc (VRCI.L) Income Statement & Financial Overview
Review Verici Dx plc's (VRCI.L) income statement with detailed quarterly and annual figures.
| Metric | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $3.34M | $497000.00 | $497000.00 | $9500.00 |
| Cost of Revenue | $0.00 | $1500.00 | $1500.00 | $1500.00 |
| Gross Profit | $3.34M | $495500.00 | $495500.00 | $8000.00 |
| Gross Profit Ratio | $1.00 | $1.00 | $1.00 | $0.84 |
| R&D Expenses | $1.002M | $394000.00 | $394000.00 | $820500.00 |
| SG&A Expenses | $4.40M | $1.84M | $1.84M | $2.46M |
| Operating Expenses | $4.79M | $2.24M | $2.24M | $2.70M |
| Total Costs & Expenses | $4.79M | $2.24M | $2.24M | $2.70M |
| Interest Income | $0.00 | $0.00 | $0.00 | $53500.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $388000.00 | $178500.00 | $178500.00 | $236000.00 |
| EBITDA | -$1.06M | -$1.34M | -$1.34M | -$2.45M |
| EBITDA Ratio | -$0.32 | -$2.69 | -$2.69 | -$258.32 |
| Operating Income | -$1.45M | -$1.74M | -$1.74M | -$2.69M |
| Operating Income Ratio | -$0.44 | -$3.51 | -$3.51 | -$283.16 |
| Other Income/Expenses (Net) | $105000.00 | $13000.00 | $13000.00 | $53500.00 |
| Income Before Tax | -$1.35M | -$1.73M | -$1.73M | -$2.64M |
| Income Before Tax Ratio | -$0.40 | -$3.48 | -$3.48 | -$277.53 |
| Income Tax Expense | $0.00 | $226500.00 | $226500.00 | $0.00 |
| Net Income | -$1.35M | -$1.73M | -$1.73M | -$2.64M |
| Net Income Ratio | -$0.40 | -$3.48 | -$3.48 | -$277.53 |
| EPS | -$0.006 | -$0.01 | -$0.01 | -$0.02 |
| Diluted EPS | -$0.006 | -$0.01 | -$0.01 | -$0.02 |
| Weighted Avg Shares Outstanding | $222.63M | $170.32M | $170.32M | $170.33M |
| Weighted Avg Shares Outstanding (Diluted) | $222.59M | $170.32M | $170.32M | $170.32M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan